Hybrid Delivery System Boosts DNA Vaccines Potential

Researchers at the University at Buffalo have developed a hybrid delivery system designed to fight cancer, HIV, flu, and other diseases Scientists from the University at Buffalo have created a novel hybrid system designed to deliver genetic antigens and elicit a strong immune response in patients, something DNA vaccines have so far failed to deliver. The hybrid, presented in the …

University of Buffalo Develops new transport System for DNA Vaccines for HIV, Malaria, HPV, and Other Major Illnesses

“By improving the delivery of DNA vaccines, we can potentially harness the human immune system in new ways to fight everything from the flu and herpes to HIV and cancer.” Blaine Pfeifer, associate professor, Department of Chemical and Biological Engineering November 25, 2014 Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines …

Jerome H. Kim appointed as Director General of IVI

September 29, 2014 The International Vaccine Institute (IVI), a Seoul-based non-profit international organization devoted to research in vaccine development and delivery for the developing world, announced the appointment of Jerome H. Kim, M.D., as the organization’s Director General, effective early 2015. “Jerome’s scientific knowledge, technical expertise, and organizational and leadership skills make him an ideal fit for the position,” said Prof. Adel A. …

A new vaccine has been found to stop rhesus macaque moneys from infection with SIV, the monkey form of the HIV virus

New Vaccine Unexpectedly Suppresses HIV Infection In Monkeys

A new vaccine has been found to stop rhesus macaque monkeys from being infected with SIV, the monkey form of the HIV virus An international research team, with scientists based in Paris-Descartes University in France, as well as the University of Chinese Medicine in Guangzhou, China, has developed a new orally administered vaccine that was found to block the SIV …

Researchers at the University of Louisville Have Developed a Gel to Stop the Spread of HIV

Federal Grant of $14.7 Million to Help HIV Vaccine Research in Owensboro

Researchers at the University of Louisville Have Developed a Gel to Stop the Spread of HIV On Monday the 4th of August, the US National Institutes of Health announced that they would be funding a five-year, $14.7 million dollar HIV research project led by the Owensboro Cancer Research program and the University of Louisville. The Louisville researchers goal is to …

Theraclone Announces Exclusive Agreement with Gilead Sciences for Broadly Neutralizing HIV Antibodies

July 30th, 2014 Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that it has entered into an agreement with Gilead Sciences, Inc., under which Gilead received an exclusive license to develop and commercialize products incorporating Theraclone’s broadly neutralizing HIV-antibodies for therapeutic applications in HIV. These broadly neutralizing antibodies (bNAbs) were discovered in collaboration with the International …

Young HIV Positive People Respond Well to HPV Vaccine

Young HIV Positive People Respond Well to HPV Vaccine

The study, Presented at the International AIDS Conference in Melbourne Last Week, Showed that the HPV Vaccine Works Just as Well for HIV-Positive Patients as it Does for HIV-Negative People Human Papillomavirus, the most common sexually transmitted infection, occurs in a variety of strains that vary in severity. People will typically become infected with HPV after they have become sexually …

Researchers from Duke University have Discovered a Way to Elicit an Immune Response in Individuals Infected With HIV-1, the Most Common Form of the Virus

HIV Vaccine on the Horizon: Researchers Design HIV Immunogens

Researchers from Duke University have Discovered a Way to Elicit an Immune Response in Individuals Infected With HIV-1, the Most Common Form of the Virus The director of the Duke Center for HIV/AIDS Vaccine Immunology and Duke Human Vaccine Institute, Dr.Barton Haynes, recently published his teams findings in the reputable scientific journal ‘Cell.’ In a previous study led by Hayes …